 | • レポートコード：MRC2012A4106 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ゴーシェ病の世界市場を広く調査・分析し、今後の市場展望をまとめております。ゴーシェ病の種類別市場規模（酵素補充療法、基質減少療法）、用途別市場規模（非神経障害性XXX、神経障害性XXX）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Sanofi、Pfizer (Protalix)、Takeda、Actelion Pharma、ISU ABXIS、 ・地域別グローバル市場分析 2015年-2020年 ・ゴーシェ病の北米市場（アメリカ、カナダ、メキシコ） ・ゴーシェ病のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ゴーシェ病のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ゴーシェ病の南米市場（ブラジル、アルゼンチン） ・ゴーシェ病の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：酵素補充療法、基質減少療法 ・用途別分析：非神経障害性XXX、神経障害性XXX ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Gaucher Disease market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Gaucher Disease market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.7%% in the forecast period of 2020 to 2025 and will expected to reach USD 1969.2 million by 2025, from USD 1771.5 million in 2019.
Market segmentation
Gaucher Disease market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Gaucher Disease market has been segmented into
Enzyme Replacement Therapy
Substrate Reduction Therapy
By Application, Gaucher Disease has been segmented into:
Non-neuronopathic Gaucher Disease
Neuronopathic Gaucher Disease
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Gaucher Disease market presented in the report. This section sheds light on the sales growth of different regional and country-level Gaucher Disease markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Gaucher Disease market.
The report offers in-depth assessment of the growth and other aspects of the Gaucher Disease market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Gaucher Disease Market Share Analysis
Gaucher Disease competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Gaucher Disease sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Gaucher Disease sales, revenue and market share for each player covered in this report.
The major players covered in Gaucher Disease are:
Sanofi
Pfizer (Protalix)
Takeda
Actelion Pharma
ISU ABXIS
Among other players domestic and global, Gaucher Disease market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gaucher Disease product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gaucher Disease, with price, sales, revenue and global market share of Gaucher Disease in 2018 and 2019.
Chapter 3, the Gaucher Disease competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gaucher Disease breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Gaucher Disease market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Gaucher Disease sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Gaucher Disease Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gaucher Disease Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Enzyme Replacement Therapy
1.2.3 Substrate Reduction Therapy
1.3 Market Analysis by Application
1.3.1 Overview: Global Gaucher Disease Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Non-neuronopathic Gaucher Disease
1.3.3 Neuronopathic Gaucher Disease
1.4 Overview of Global Gaucher Disease Market
1.4.1 Global Gaucher Disease Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi SWOT Analysis
2.1.4 Sanofi Product and Services
2.1.5 Sanofi Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pfizer (Protalix)
2.2.1 Pfizer (Protalix) Details
2.2.2 Pfizer (Protalix) Major Business
2.2.3 Pfizer (Protalix) SWOT Analysis
2.2.4 Pfizer (Protalix) Product and Services
2.2.5 Pfizer (Protalix) Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Takeda
2.3.1 Takeda Details
2.3.2 Takeda Major Business
2.3.3 Takeda SWOT Analysis
2.3.4 Takeda Product and Services
2.3.5 Takeda Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Actelion Pharma
2.4.1 Actelion Pharma Details
2.4.2 Actelion Pharma Major Business
2.4.3 Actelion Pharma SWOT Analysis
2.4.4 Actelion Pharma Product and Services
2.4.5 Actelion Pharma Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 ISU ABXIS
2.5.1 ISU ABXIS Details
2.5.2 ISU ABXIS Major Business
2.5.3 ISU ABXIS SWOT Analysis
2.5.4 ISU ABXIS Product and Services
2.5.5 ISU ABXIS Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Gaucher Disease Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Gaucher Disease Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Gaucher Disease Manufacturer Market Share in 2019
3.3.2 Top 6 Gaucher Disease Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Gaucher Disease Sales, Revenue and Market Share by Regions
4.1.1 Global Gaucher Disease Sales and Market Share by Regions (2015-2020)
4.1.2 Global Gaucher Disease Revenue and Market Share by Regions (2015-2020)
4.2 North America Gaucher Disease Sales and Growth Rate (2015-2020)
4.3 Europe Gaucher Disease Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Gaucher Disease Sales and Growth Rate (2015-2020)
4.5 South America Gaucher Disease Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Gaucher Disease Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Gaucher Disease Sales, Revenue and Market Share by Country
5.1.1 North America Gaucher Disease Sales and Market Share by Country (2015-2020)
5.1.2 North America Gaucher Disease Revenue and Market Share by Country (2015-2020)
5.2 United States Gaucher Disease Sales and Growth Rate (2015-2020)
5.3 Canada Gaucher Disease Sales and Growth Rate (2015-2020)
5.4 Mexico Gaucher Disease Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Gaucher Disease Sales, Revenue and Market Share by Country
6.1.1 Europe Gaucher Disease Sales and Market Share by Country (2015-2020)
6.1.2 Europe Gaucher Disease Revenue and Market Share by Country (2015-2020)
6.2 Germany Gaucher Disease Sales and Growth Rate (2015-2020)
6.3 UK Gaucher Disease Sales and Growth Rate (2015-2020)
6.4 France Gaucher Disease Sales and Growth Rate (2015-2020)
6.5 Russia Gaucher Disease Sales and Growth Rate (2015-2020)
6.6 Italy Gaucher Disease Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Gaucher Disease Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Gaucher Disease Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Gaucher Disease Revenue and Market Share by Regions (2015-2020)
7.2 China Gaucher Disease Sales and Growth Rate (2015-2020)
7.3 Japan Gaucher Disease Sales and Growth Rate (2015-2020)
7.4 Korea Gaucher Disease Sales and Growth Rate (2015-2020)
7.5 India Gaucher Disease Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Gaucher Disease Sales and Growth Rate (2015-2020)
7.7 Australia Gaucher Disease Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Gaucher Disease Sales, Revenue and Market Share by Country
8.1.1 South America Gaucher Disease Sales and Market Share by Country (2015-2020)
8.1.2 South America Gaucher Disease Revenue and Market Share by Country (2015-2020)
8.2 Brazil Gaucher Disease Sales and Growth Rate (2015-2020)
8.3 Argentina Gaucher Disease Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Gaucher Disease Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Gaucher Disease Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Gaucher Disease Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Gaucher Disease Sales and Growth Rate (2015-2020)
9.3 Turkey Gaucher Disease Sales and Growth Rate (2015-2020)
9.4 Egypt Gaucher Disease Sales and Growth Rate (2015-2020)
9.5 South Africa Gaucher Disease Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Gaucher Disease Sales and Market Share by Type (2015-2020)
10.2 Global Gaucher Disease Revenue and Market Share by Type (2015-2020)
10.3 Global Gaucher Disease Price by Type (2015-2020)
11 Global Gaucher Disease Market Segment by Application
11.1 Global Gaucher Disease Sales Market Share by Application (2015-2020)
11.2 Global Gaucher Disease Revenue Market Share by Application (2015-2020)
11.3 Global Gaucher Disease Price by Application (2015-2020)
12 Market Forecast
12.1 Global Gaucher Disease Sales, Revenue and Growth Rate (2021-2025)
12.2 Gaucher Disease Market Forecast by Regions (2021-2025)
12.2.1 North America Gaucher Disease Market Forecast (2021-2025)
12.2.2 Europe Gaucher Disease Market Forecast (2021-2025)
12.2.3 Asia-Pacific Gaucher Disease Market Forecast (2021-2025)
12.2.4 South America Gaucher Disease Market Forecast (2021-2025)
12.2.5 Middle East & Africa Gaucher Disease Market Forecast (2021-2025)
12.3 Gaucher Disease Market Forecast by Type (2021-2025)
12.3.1 Global Gaucher Disease Sales Forecast by Type (2021-2025)
12.3.2 Global Gaucher Disease Market Share Forecast by Type (2021-2025)
12.4 Gaucher Disease Market Forecast by Application (2021-2025)
12.4.1 Global Gaucher Disease Sales Forecast by Application (2021-2025)
12.4.2 Global Gaucher Disease Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Gaucher Disease Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Gaucher Disease by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Gaucher Disease Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Gaucher Disease Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Sanofi Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Gaucher Disease Major Business
Table 10. Sanofi Gaucher Disease Total Revenue (USD Million) (2018-2019)
Table 11. Sanofi SWOT Analysis
Table 12. Sanofi Gaucher Disease Product and Services
Table 13. Sanofi Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Pfizer (Protalix) Basic Information, Manufacturing Base and Competitors
Table 15. Pfizer (Protalix) Gaucher Disease Major Business
Table 16. Pfizer (Protalix) Gaucher Disease Total Revenue (USD Million) (2018-2019)
Table 17. Pfizer (Protalix) SWOT Analysis
Table 18. Pfizer (Protalix) Gaucher Disease Product and Services
Table 19. Pfizer (Protalix) Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Takeda Basic Information, Manufacturing Base and Competitors
Table 21. Takeda Gaucher Disease Major Business
Table 22. Takeda Gaucher Disease Total Revenue (USD Million) (2018-2019)
Table 23. Takeda SWOT Analysis
Table 24. Takeda Gaucher Disease Product and Services
Table 25. Takeda Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Actelion Pharma Basic Information, Manufacturing Base and Competitors
Table 27. Actelion Pharma Gaucher Disease Major Business
Table 28. Actelion Pharma Gaucher Disease Total Revenue (USD Million) (2018-2019)
Table 29. Actelion Pharma SWOT Analysis
Table 30. Actelion Pharma Gaucher Disease Product and Services
Table 31. Actelion Pharma Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. ISU ABXIS Basic Information, Manufacturing Base and Competitors
Table 33. ISU ABXIS Gaucher Disease Major Business
Table 34. ISU ABXIS Gaucher Disease Total Revenue (USD Million) (2018-2019)
Table 35. ISU ABXIS SWOT Analysis
Table 36. ISU ABXIS Gaucher Disease Product and Services
Table 37. ISU ABXIS Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Global Gaucher Disease Sales by Manufacturer (2018-2019) (K Units)
Table 39. Global Gaucher Disease Revenue by Manufacturer (2018-2019) (USD Million)
Table 40. Global Gaucher Disease Sales by Regions (2015-2020) (K Units)
Table 41. Global Gaucher Disease Sales Market Share by Regions (2015-2020)
Table 42. Global Gaucher Disease Revenue by Regions (2015-2020) (USD Million)
Table 43. North America Gaucher Disease Sales by Countries (2015-2020) (K Units)
Table 44. North America Gaucher Disease Sales Market Share by Countries (2015-2020)
Table 45. North America Gaucher Disease Revenue by Countries (2015-2020) (USD Million)
Table 46. North America Gaucher Disease Revenue Market Share by Countries (2015-2020)
Table 47. Europe Gaucher Disease Sales by Countries (2015-2020) (K Units)
Table 48. Europe Gaucher Disease Sales Market Share by Countries (2015-2020)
Table 49. Europe Gaucher Disease Revenue by Countries (2015-2020) (USD Million)
Table 50. Asia-Pacific Gaucher Disease Sales by Regions (2015-2020) (K Units)
Table 51. Asia-Pacific Gaucher Disease Sales Market Share by Regions (2015-2020)
Table 52. Asia-Pacific Gaucher Disease Revenue by Regions (2015-2020) (USD Million)
Table 53. South America Gaucher Disease Sales by Countries (2015-2020) (K Units)
Table 54. South America Gaucher Disease Sales Market Share by Countries (2015-2020)
Table 55. South America Gaucher Disease Revenue by Countries (2015-2020) (USD Million)
Table 56. South America Gaucher Disease Revenue Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Gaucher Disease Sales by Countries (2015-2020) (K Units)
Table 58. Middle East & Africa Gaucher Disease Sales Market Share by Countries (2015-2020)
Table 59. Middle East & Africa Gaucher Disease Revenue by Countries (2015-2020) (USD Million)
Table 60. Middle East & Africa Gaucher Disease Revenue Market Share by Countries (2015-2020)
Table 61. Global Gaucher Disease Sales by Type (2015-2020) (K Units)
Table 62. Global Gaucher Disease Sales Share by Type (2015-2020)
Table 63. Global Gaucher Disease Revenue by Type (2015-2020) (USD Million)
Table 64. Global Gaucher Disease Revenue Share by Type (2015-2020)
Table 65. Global Gaucher Disease Sales by Application (2015-2020) (K Units)
Table 66. Global Gaucher Disease Sales Share by Application (2015-2020)
Table 67. Global Gaucher Disease Sales Forecast by Regions (2021-2025) (K Units)
Table 68. Global Gaucher Disease Market Share Forecast by Regions (2021-2025)
Table 69. Global Gaucher Disease Sales Forecast by Type (2021-2025) (K Units)
Table 70. Global Gaucher Disease Market Share Forecast by Type (2021-2025)
Table 71. Global Gaucher Disease Sales Forecast by Application (2021-2025)
Table 72. Global Gaucher Disease Market Share Forecast by Application (2021-2025)
Table 73. Direct Channel Pros & Cons
Table 74. Indirect Channel Pros & Cons
Table 75. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Gaucher Disease Picture
Figure 2. Global Sales Market Share of Gaucher Disease by Type in 2019
Figure 3. Enzyme Replacement Therapy Picture
Figure 4. Substrate Reduction Therapy Picture
Figure 5. Gaucher Disease Sales Market Share by Application in 2019
Figure 6. Non-neuronopathic Gaucher Disease Picture
Figure 7. Neuronopathic Gaucher Disease Picture
Figure 8. Global Gaucher Disease Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Gaucher Disease Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Gaucher Disease Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Gaucher Disease Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Gaucher Disease Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Gaucher Disease Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Gaucher Disease Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Gaucher Disease Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Gaucher Disease Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Gaucher Disease Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Gaucher Disease Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Gaucher Disease Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Gaucher Disease Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Gaucher Disease Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Gaucher Disease Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Gaucher Disease Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Gaucher Disease Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Gaucher Disease Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Gaucher Disease Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Gaucher Disease Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Gaucher Disease Sales Market Share by Manufacturer in 2019
Figure 29. Global Gaucher Disease Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Gaucher Disease Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Gaucher Disease Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Gaucher Disease Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global Gaucher Disease Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Gaucher Disease Revenue Market Share by Regions (2015-2020)
Figure 36. Global Gaucher Disease Revenue Market Share by Regions in 2018
Figure 37. North America Gaucher Disease Sales and Growth Rate (2015-2020)
Figure 38. Europe Gaucher Disease Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Gaucher Disease Sales and Growth Rate (2015-2020)
Figure 40. South America Gaucher Disease Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Gaucher Disease Sales and Growth Rate (2015-2020)
Figure 42. North America Gaucher Disease Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Gaucher Disease Sales Market Share by Countries (2015-2020)
Figure 44. North America Gaucher Disease Sales Market Share by Countries in 2018
Figure 45. North America Gaucher Disease Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Gaucher Disease Revenue Market Share by Countries in 2018
Figure 47. United States Gaucher Disease Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada Gaucher Disease Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico Gaucher Disease Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe Gaucher Disease Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Gaucher Disease Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Gaucher Disease Revenue Market Share by Countries in 2019
Figure 53. Germany Gaucher Disease Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK Gaucher Disease Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France Gaucher Disease Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia Gaucher Disease Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy Gaucher Disease Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific Gaucher Disease Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Gaucher Disease Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Gaucher Disease Revenue Market Share by Regions 2019
Figure 61. China Gaucher Disease Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan Gaucher Disease Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea Gaucher Disease Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India Gaucher Disease Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia Gaucher Disease Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America Gaucher Disease Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Gaucher Disease Sales Market Share by Countries in 2019
Figure 68. South America Gaucher Disease Revenue Market Share by Countries in 2019
Figure 69. Brazil Gaucher Disease Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Gaucher Disease Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa Gaucher Disease Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Gaucher Disease Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Gaucher Disease Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Gaucher Disease Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Gaucher Disease Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt Gaucher Disease Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey Gaucher Disease Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa Gaucher Disease Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global Gaucher Disease Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global Gaucher Disease Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Gaucher Disease Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales Gaucher Disease Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales Gaucher Disease Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales Gaucher Disease Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales Gaucher Disease Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
ゴーシェ病治療の世界市場（～2026年） Market Analysis and Insights: Global Gaucher Disease Treatment Market The global Gaucher Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Gaucher Disease Treatment Scope and Market Size Gaucher Disease…- ゴーシェ病治療薬の世界市場（～2026年） Market Analysis and Insights: Global Gaucher Disease Drugs Market The global Gaucher Disease Drugs market size is projected to reach US$ 1330 million by 2026, from US$ 1321 million in 2020, at a CAGR of 0.6%% during 2021-2026. Global Gaucher Disease Drugs Scope and Market Size Gaucher Disease Drugs …
- クラッベ病治療の世界市場（～2026年） Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessi…
- フォンウィルブランド病（VWD）治療薬の世界市場（～2026年） Von Willebrand Disease is an inherited bleeding disorder that is caused by deficiency or dysfunction of Von Willebrand Factor (VWF). VWF is a plasma protein that mediates the initial adhesion of platelets at sites of vascular injury. This protein also binds to clotting factor VIII (FVIII) in the cir…
- クローン病の世界市場（～2026年） Crohn’s disease refers to long term inflammatory bowel disease, which causes inflammation of the lining of the digestive tract. It affects the large and small intestine and is generally diagnosed in persons within the age group of 20-29. It can have severe or acute outcomes. Signs and symptoms of Cr…